U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07243756) titled 'Gut Microbiome Pill' on Nov. 17.
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of a 3D-printed ingestible pill designed to sample microbiota from the GI tract, focusing on the ability to collect data also from the small intestine. The study also aims to assess ease of use and transit time.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DEVICE: 3D-printed ingestible pill
The pill consists of a microporous architecture specifically designed to trap bacteria. The pill contains a ferrous (iron) ball for detection with a metal detection device and passes n...